Call Options Transactions Made in Q4 2023 in Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX) during Q4 2023. The information is specifically focused on institutions that hold call options of RECURSION PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
76.2K+ 34.39% |
$388K - $822K
|
298K
$1.84M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
49.5K+ 62.9% |
$252K - $534K
|
128K
$792K
|
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
25KNew |
$127K - $270K
|
25K
$155K
|
|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
6.1K+ 42.66% |
$31K - $65.8K
|
20.4K
$126K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
CALL |
600New |
$3.05K - $6.47K
|
600
$3.71K
|